drugset / Trial / NCT06217666
Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether a new treatment combining radiation therapy with PCX12 is safe and tolerable.
Timeline
- Start
- 2026-12-01
- Primary completion
- 2028-12
- Completion
- 2029-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PCX12 | Unknown | 200 ng | Other |
| Subject | PCX12 | Unknown | 800 ng | Other |